BMRN vs GBDC · P/E 40, rev $1.76B vs P/E 16, $3.22B cap
Biomarin Pharmaceutical Inc (BMRN) versus Golub Capital BDC Inc (GBDC) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Golub Capital BDC Inc (GBDC) is a asset management company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
GBDC does not have a complete income-statement cache yet.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. GBDC currently screens at market cap $3.22B and trailing P/E 16.0.
Not investment advice. Open the BMRN and GBDC stock pages for the full models.
Not investment advice.